Clinical and Genetic Study of Algerian Patients with Spinal Muscular Atrophy
Journal of Neurodegenerative Diseases · 2013
DOI: 10.1155/2013/903875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurodegenerative Diseases, 2013. Verfasst von Y Sifi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Service of Neurology CHU of Constantine, Algeria ; Laboratory of Biology and Molecular Genetics CHU and University of Constantine, Algeria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Spinal muscular atrophy ( SMA ) is the second most common lethal autosomal recessive disorder. It is divided into the acute Werdnig-Hoffmann disease (type I), the intermediate form (type II), the Kugelberg-Welander disease (type III), and the adult form (type IV). The gene involved in all four forms of SMA , the so-called survival motor neuron ( SMN ) gene, is duplicated, with a telomeric (tel SMN or SMN 1) and a centromeric copy (cent SMN or SMN 2). SMN 1 is homozygously deleted in over 95% of SMA patients. Another candidate gene in SMA is the neuronal apoptosis inhibitory protein ( NAIP ) gene; it shows homozygous deletions in 45–67% of type I and 20–42% of type II/type III patients. Here we studied the SMN and NAIP genes in 92 Algerian SMA patients (20 type I, 16 type II, 53 type III, and 3 type IV) from 57 unrelated families, using a semiquantitative PCR approach. Homozygous deletions of SMN 1 exons 7 and/or 8 were found in 75% of the families. Deletions of exon 4 and/or 5 of the NAIP gene were found in around 25%. Conversely, the quantitative analysis of SMN 2 copies showed a significant correlation between SMN 2 copy number and the type of SMA .
Autor:innen und Institutionen
- Service of Neurology CHU of Constantine, Algeria ; Laboratory of Biology and Molecular Genetics CHU and University of Constantine, Algeria.
- Laboratory of Biology and Molecular Genetics CHU and University of Constantine, Algeria ; Laboratory of Biochemistry CHU of Constantine, Algeria.
- Service of Pediatrics CHU de Constantine, Algeria.
- Genetic Department of the Necker Hospital and Paris Descartes University, Paris, France.
- Service of Neurology CHU of Constantine, Algeria ; Laboratory of Biochemistry CHU of Constantine, Algeria.
Zitieren
APA
Sifi, Y., Sifi, K., Boulefkhad, A., Abadi, N., Bouderda, Z., Cheriet, R., Magen, M., Bonnefont, J. P., Munnich, A., Benlatreche, C., & Hamri, A. (2013). Clinical and Genetic Study of Algerian Patients with Spinal Muscular Atrophy. Journal of Neurodegenerative Diseases. https://doi.org/10.1155/2013/903875
Vancouver
Sifi Y, Sifi K, Boulefkhad A, Abadi N, Bouderda Z, Cheriet R, et al. Clinical and Genetic Study of Algerian Patients with Spinal Muscular Atrophy. Journal of Neurodegenerative Diseases. 2013. doi:10.1155/2013/903875
BibTeX
@article{Sifi2013,
author = {Sifi, Y and Sifi, K and Boulefkhad, A and Abadi, N and Bouderda, Z and Cheriet, R and Magen, M and Bonnefont, J P and Munnich, A and Benlatreche, C and Hamri, A},
title = {Clinical and Genetic Study of Algerian Patients with Spinal Muscular Atrophy},
journal = {Journal of Neurodegenerative Diseases},
year = {2013},
doi = {10.1155/2013/903875}
}
EUVIMED